Methylbenzylpiperazine
Methylbenzylpiperazine (MBZP) is a stimulant drug which is a derivative of piperazine. This substance is closely related to benzylpiperazine (BZP) and trifluoromethylphenylpiperazine (TFMPP) and has similar effects to these drugs. MBZP has been sold as an ingredient in legal recreational drugs known as "party pills", initially in New Zealand and subsequently in other countries around the world.
Chemistry[edit]
MBZP is classified as a piperazine, which is a class of substances derived from the organic compound piperazine. Piperazines are used in a variety of applications, including as antihelminthics (drugs that expel parasitic worms) and in the manufacture of plastics, resins, pesticides, brake fluid and other industrial materials. MBZP is a derivative of piperazine, meaning it shares the same basic chemical structure but has additional chemical groups attached.
Pharmacology[edit]
The pharmacological action of MBZP is similar to that of other piperazine derivatives. These substances act as stimulants, increasing the activity of the central nervous system. This can result in increased alertness, euphoria, and a sense of increased energy and wellbeing. However, these effects are often accompanied by side effects such as insomnia, anxiety, and potentially dangerous increases in heart rate and blood pressure.
Legal status[edit]
The legal status of MBZP varies by country. In some jurisdictions, it is classified as a controlled substance and its sale, possession, or use may be subject to legal penalties. In other jurisdictions, it may be legal to possess but not to sell, or it may be entirely unregulated.
Health effects[edit]
Like other stimulant drugs, MBZP can have a range of health effects. These can include insomnia, anxiety, increased heart rate and blood pressure, and in extreme cases, seizures or heart failure. Chronic use of MBZP can also lead to dependence and withdrawal symptoms.
See also[edit]
-
Methylbenzylpiperazine
-
Methylbenzylpiperazine 3D structure
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
